LDS buys Kaolectrolyte, Prodium
This article was originally published in The Tan Sheet
Executive Summary
Cedar Rapids, Iowa-based LDS Consumer Products acquires U.S. marketing, distribution rights to Kaolectrolyte oral rehydration therapy for infants, children under six and Prodium urinary tract infection treatment from Requa, firm announces June 6. Kaolectrolyte competes against Ross' Pedialyte, while Prodium competitors include J&J's Uristat and PolyMedica's Azo-Standard; all three contain active phenazopyridine 95 mg. LDS obtained exclusive U.S. sales and marketing rights to Wartner Wart Removal System in 2002 (1"The Tan Sheet" April 28, 2003, p. 4)...
You may also be interested in...
Wartner Cryotherapy Product Looks To Freeze Wart Removal Competition
LDS Consumer Products' Wartner is the first OTC wart removal product featuring cryotherapy technology, according to the Cedar Rapids, Iowa-based firm
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.